Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 451-900-9 | CAS number: 894406-76-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity
A study was carried out according to OECD Guideline 401 (Acute Oral Toxicity) and US FIFRA (40 CFR). The study revealed a LD50 of 245 mg a.i./kg bw (135 – 443 mg a.i./kg bw) and a NOEL of 25 mg a.i./kg bw.
Acute inhalation toxicity
According to column 2 of REACH Regulation (EC) No 1907/2006 Annex VIII, section 8.5 testing by the inhalation route was waived, as an acute oral toxicity study and an acute dermal toxicity study are available. Only two acute dose toxicity studies are required, with test item administration via the most appropriate routes.
Acute dermal toxicity
A study was carried out according to EU Method B.3 and OECD Guideline 402 (Acute Dermal Toxicity). Due to the severity of the dermal reactions, tested animals were killed in extremis one day after dosing. There were no signs of systemic toxicity. Signs of dermal irritation were indicative of dermal corrosion. No abnormalities were noted at necropsy. Therefore, the acute dermal median lethal dose may be considered to be greater than 2000 mg/kg bw although there is insufficient data available to confirm this finding.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study according to international guidelines.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- other: FIFRA (40 CFR)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: Young adults
- Weight at study initiation:
Male: 242 – 300 g
Female: 189 – 254 g - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 5 % - Doses:
- Dose range finding: 100, 250, 500 mg a.i./kg
Definitive test: 25, 50, 100, 200, 400, 800 mg a.i./kg - No. of animals per sex per dose:
- Dose range finding: 2/sex/group
Definitive test: 5/sex/group - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Day 0, 7 and 14
- Necropsy of survivors performed: Yes
- Other examinations performed: Clinical signs
In addition the post-exposure observation period was extended to 21 days for those rats exposed to 200 and 400 mg/kg of Carboquat due to the toxic effects observed on day 14. - Preliminary study:
- For results see table 1a below. Definitive test doses were based on the results obtained in the preliminary test.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 245 mg/kg bw
- Based on:
- act. ingr.
- 95% CL:
- 135 - 443
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- 25 mg/kg bw
- Based on:
- act. ingr.
- Mortality:
- For results see table 1b below.
- Clinical signs:
- other: A variety of clinical signs were observed for males and females in the 800 mg a.i./kg bw treatment group which died as a result of treatment. These signs were generally indicative of increased secretions, changes in the appearance of the fur and posture,
- Gross pathology:
- Findings in the animals that died during the observation period were those generally seen in agonal animals with additional observation generally seen in response to the oral administration of an irritating material. All animals at the 400 mg a.i./kg bw dose level and one animal at the 200 mg a.i./kg bw dose level which survived the observation period exhibited tissue adhesions in the peritoneal cavity in the area of the stomach. Furthermore, all animals which survived the observation period at the 100 mg a.i./kg bw dose level exhibited livers and spleens which appeared pitted. In all other animals which survived the observation period there were no gross pathological findings.
- Interpretation of results:
- harmful
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute oral toxicity study revealed a LD50 of 245 mg a.i./kg bw (135 – 443 mg a.i./kg bw) and a NOEL of 25 mg a.i./kg bw.
- Executive summary:
A study was carried out according to OECD Guideline 401 (Acute Oral Toxicity) and US FIFRA (40 CFR). The study was performed on male and female Sprague Dawley rats at dose levels of 800, 400, 200, 100, 50 and 25 mg a.i./kg bw. All levels were dosed with a 5 % w/w aqueous formulation of DDACarbonate. Rats were observed for 14 days post-dosing. A gross necropsy was performed on any animal that died and at the end of the observation period, all animals were sacrificed for gross necropsy. The acute oral toxicity study revealed a LD50 of 245 mg a.i./kg bw (135 – 443 mg a.i./kg bw) and a NOEL of 25 mg a.i./kg bw.
Reference
Table 1a: Group incidence of mortality - Dose range finding screen:
Dose |
Mortality |
|
Male |
Female |
|
500 |
2/2 |
2/2 |
250 |
2/2 |
2/2 |
100 |
0/2 |
0/2 |
Table 1b: Group incidence of mortality - Definitive test
Dose |
Mortality |
|
Male |
Female |
|
800 |
5/5 |
5/5 |
400 |
2/5 |
4/5 |
200 |
2/5 |
3/5 |
100 |
1/5 |
0/5 |
50 |
0/5 |
1/5 |
25 |
0/5 |
0/5 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 245 mg/kg bw
- Quality of whole database:
- High quality database.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Safepharm Laboratories Ltd
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- On receipt the animals were randomly allocated to cages. The female was nulliparous and non-pregnant. After an acclimatisation period of at least five days the animals were selected at random and given a number unique within the study by a number written on a cage card. At the start of the study the animals weighed at least 200g, and were eight to twelve weeks of age.
The animals were housed in suspended solid-floor polypropylene cages furnished with woodflakes. The animals were housed individually. Free access to mains drinking water and food (Certified Rat and Mouse Diet (Code 5LF2) supplied by BCM IPS Limited, London, UK) was allowed throughout the study. The diet, drinking water and bedding were routinely analysed and were considered not to contain any contaminants that could reasonably be expected to affect the purpose or integrity of the study.
The temperature and relative humidity were set to achieve limits of 19 to 25 °C and 30 to 70 % respectively. Any occasional deviations from these targets were considered not to have affected the purpose or integrity of the study. The rate of air exchange was at least fifteen changes per hour and the lighting was controlled by a time switch to give twelve hours continuous light (06:00 to 18:00) and twelve hours darkness.
The animals were provided with environmental enrichment items which were considered not to contain any contaminant of a level that might have affected the purpose or integrity of the study.
IN-LIFE DATES: 09 June 2004 and 10 June 2004 - Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- The study was performed to assess the dermal toxicity of the test material in the rat. Two animals (one male and one female) were given a single, 24 hour, semi-occluded dermal application of the undiluted test material to intact skin at a dose level of 2000 mg/kg bw. Clinical signs and bodyweight development were monitored during the study. All animals were subjected to gross necropsy at termination of the study.
TEST SITE
- Area of exposure: back and flanks
- % coverage: approximately 10% of the total body surface area
- Type of wrap if used: surgical gauze
REMOVAL OF TEST SUBSTANCE
- Washing (if done): the treated skin and surrounding hair wiped with cotton wool moistened with arachis oil BP to remove any residual test material
- Time after start of exposure: 24-hour
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2.09 mL/kg - Duration of exposure:
- 24 hours
- Doses:
- Limit test 2000 mg/kg bw
- No. of animals per sex per dose:
- 1 male and 1 female animal
- Control animals:
- not required
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The animals were observed for deaths or overt signs of toxicity 0.5, 1, 2, 4 hours and one day after dosing.
- Necropsy of survivors performed: Yes
- Other examinations performed: Clinical signs - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- >= 2 000 mg/kg bw
- Based on:
- act. ingr.
- Remarks on result:
- other: Due to the severity of the dermal reactions noted in the initial two animals, resulting in these animals being killed in extremis one day after dosing, no further animals were treated.
- Mortality:
- Due to the severity of the dermal reactions, both animals were killed in extremis one day after dosing.
- Clinical signs:
- other: Signs of dermal irritation noted were brown/green coloured dermal necrosis (attributed a Draize score of 4 for erythema due to injuries in depth), surrounded by a thin margin of blanching and moderate oedema. Well-defined erythema surrounding other dermal
- Gross pathology:
- No abnormalities detected.
- Interpretation of results:
- harmful
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The animals showed no signs of toxicity but were killed in extremis due to the severity of the dermal reactions. The acute dermal median lethal dose may be considered to be greater than 2000 mg/kg bw although there is insufficient data available to confirm this finding.
- Executive summary:
A study was carried out according to EU Method B.3 and OECD Guideline 402 (Acute Dermal Toxicity). The study was performed to assess the dermal toxicity of the test material in the rat. Two animals (one male and one female) were given a single, 24 hour, semi-occluded dermal application of the undiluted test material to intact skin at a dose level of 2000 mg/kg bw. Clinical signs and bodyweight development were monitored during the study. All animals were subjected to gross necropsy at termination of the study.
Due to the severity of the dermal reactions, both animals were killed in extremis one day after dosing. There were no signs of systemic toxicity. Signs of dermal irritation were indicative of dermal corrosion. No abnormalities were noted at necropsy. The acute dermal median lethal dose may be considered to be greater than 2000 mg/kg bw although there is insufficient data available to confirm this finding.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- High quality database.
Additional information
GLP study according to international guidelines.
Justification for selection of acute toxicity – dermal endpoint
GLP study according to international guidelines.
Justification for classification or non-classification
Based on the information available the substance is classified and labeled as Acute Toxicity Cat. 4, H302: Harmful if swallowed according to Regulation (EC) No 1272/2008 (CLP) and Xn, R21: Harmful in contact with skin and R22: Harmful if swallowed according to Directive 67/548/EEC (DSD).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.